Found 1670 clinical trials
Hypertension Intracranial Pulsatility and Brain Amyloid-beta Accumulation in Older Adults (HIPAC Trial)
treating high blood pressure alters brain pulsatility, which in turn reduces brain amyloid beta protein accumulation and improves brain structure and function.
- 98 views
- 21 Mar, 2022
- 1 location
Hypertension
The purpose of this study is to evaluate the effect of ALN-AGT01 on systolic and diastolic blood pressure and to characterize the pharmacodynamic (PD) effects and safety of ALN-AGT01.
- 0 views
- 18 Apr, 2022
- 1 location
Hypertension
The purpose of this study is to evaluate the effect of zilebesiran on systolic and diastolic blood pressure and to characterize the pharmacodynamic (PD) effects and safety of zilebesiran as add-on therapy.
- 0 views
- 18 Apr, 2022
- 1 location
Uncontrolled Blood Pressure
We are currently seeking participants for a clinical study to evaluate the efficacy of an investigational medication for individuals with high blood pressure.
- 0 views
- 07 Apr, 2022
- 1 location
Healthy Male Research Study
Looking for males 18-65 years of age, non-smokers, no drug or alcohol in take within past 30 years, no history of cancer, hep, hiv, high cholesterol or high blood pressure. Restrictions apply.
- 557 views
- 23 Nov, 2020
- 1 location
Join a Clinical Research Trial! Study # S-3051
Altasciences LA, formerly WCCT Global (located in Cypress, CA), is looking for healthy volunteers for an upcoming clinical study.
- 0 views
- 04 May, 2022
- 1 location
Crest-2: CAROTID REVASCULARIZATION AND MEDICAL MANAGEMENT FOR ASYMPTOMATIC CAROTID STENOSIS TRIAL (CREST-2) PROTOCOL
Carotid revascularization for primary prevention of stroke (CREST-2) is two independent multicenter, randomized controlled trials of carotid revascularization and intensive medical management versus medical management alone in patients with asymptomatic high-grade carotid stenosis. One trial will randomize patients in a 1:1 ratio to endarterectomy versus no endarterectomy and another will …
- 0 views
- 08 Jan, 2022
- 1 location
A randomized, double-blind, placebo-controlled, parallel-group, multicenter Phase 3 study to investigate the efficacy and safety of finerenone, in addition to standard of care, on the progression of kidney disease in patients with non-diabetic chronic kidney disease
We are currently recruiting participants for a clinical research study to evaluate new dosages of an FDA approved once daily medication to help improve kidney function in non-diabetic patients with Chronic Kidney Disease.
- 10 views
- 05 Nov, 2021
- 1 location
